DNA Polymerase I vs III: Functional Roles in Prokaryotic Replication

DNA polymerase I and DNA polymerase III are distinct enzymes in prokaryotic cells that perform separate tasks during DNA replication. DNA polymerase III is the primary replicative enzyme that synthesizes new DNA strands at high speed and with high processivity, while DNA polymerase I removes RNA primers and fills the resulting gaps with DNA during Okazaki fragment maturation. This article explains the enzymatic activities, structural differences, and practical implications of these two polymerases for laboratory students, technicians, researchers, and diagnostic professionals who work with prokaryotic systems.

At a Glance

The table below summarizes the key functional differences between DNA polymerase I and DNA polymerase III in prokaryotic replication.

These differences determine which enzyme performs which task during replication. DNA polymerase III handles the bulk of DNA synthesis because it can stay bound to the template for long stretches. DNA polymerase I acts after DNA polymerase III has laid down new DNA, removing the RNA primers that initiated synthesis and replacing them with DNA.

Core Principles of Prokaryotic DNA Replication

Prokaryotic DNA replication begins at a specific origin of replication where the double helix is unwound to expose single-stranded templates. The replication machinery must synthesize new DNA in the 5' to 3' direction, which creates an asymmetry because the two template strands run in opposite directions.

The leading strand is synthesized continuously in the same direction as the replication fork movement. The lagging strand is synthesized discontinuously in short segments called Okazaki fragments. Each Okazaki fragment begins with a short RNA primer synthesized by primase, and this primer must later be removed and replaced with DNA.

DNA polymerase III is the enzyme that extends both the leading strand and each Okazaki fragment from the RNA primer. DNA polymerase I then removes the RNA primer from each Okazaki fragment and fills the gap with DNA. A DNA ligase finally seals the nick between adjacent fragments to create a continuous sugar-phosphate backbone.

This division of labor means that both enzymes are essential for complete and accurate replication. A cell lacking functional DNA polymerase III cannot replicate its chromosome. A cell lacking functional DNA polymerase I accumulates unprocessed Okazaki fragments with RNA primers still attached.

Enzymatic Activities of DNA Polymerase I

DNA polymerase I is a single polypeptide enzyme that carries three distinct catalytic activities in separate domains. The enzyme has a 5' to 3' polymerase activity, a 3' to 5' exonuclease activity, and a 5' to 3' exonuclease activity.

The 5' to 3' polymerase activity adds nucleotides to the 3' hydroxyl end of a growing DNA chain. This activity is used to fill gaps left after primer removal and to extend DNA during repair processes.

The 3' to 5' exonuclease activity removes nucleotides from the 3' end of a growing chain. This proofreading function checks each newly added nucleotide and removes mismatched bases before the next nucleotide is added. This activity reduces the error rate of DNA synthesis.

The 5' to 3' exonuclease activity removes nucleotides from the 5' end of a DNA or RNA strand. This activity is essential for removing RNA primers from Okazaki fragments. The enzyme can recognize the junction between RNA and DNA and cleave the RNA portion while leaving the DNA intact.

Research on the 5' to 3' exonuclease domain of DNA polymerase I from Streptococcus pneumoniae has identified specific amino acid residues that are critical for this activity. Mutations at conserved residues including Asp10, Glu88, and Glu114 reduced exonuclease activity in experimental studies. The same study found that Asp10 plays a critical role in the catalytic event, Glu114 contributes to both catalysis and DNA binding, and Glu88 is nonessential for exonuclease activity. These findings demonstrate that the 5' to 3' exonuclease domain has a defined active site with specific residues that coordinate the cleavage reaction.

The Klenow fragment is a proteolytic cleavage product of DNA polymerase I that retains the polymerase and 3' to 5' exonuclease activities but lacks the 5' to 3' exonuclease activity. This fragment is widely used in molecular biology laboratories for DNA labeling and sequencing reactions because it does not degrade primers or synthesized products.

Enzymatic Activities of DNA Polymerase III

DNA polymerase III is a large multi-subunit complex with a holoenzyme structure that includes a catalytic core, a sliding clamp, and a clamp loader. The catalytic core contains the alpha subunit with polymerase activity, the epsilon subunit with 3' to 5' exonuclease activity, and the theta subunit that stabilizes the complex.

The alpha subunit carries the 5' to 3' polymerase activity that synthesizes new DNA. The epsilon subunit provides the proofreading 3' to 5' exonuclease activity that removes misincorporated nucleotides. The theta subunit has a structural role and helps maintain the integrity of the core complex.

The sliding clamp is a ring-shaped protein that encircles the DNA template and tethers the catalytic core to the template. This clamp dramatically increases processivity by preventing the polymerase from dissociating after each nucleotide addition. The clamp loader uses energy from ATP hydrolysis to open the clamp and place it around the DNA.

DNA polymerase III lacks a 5' to 3' exonuclease activity. This means the enzyme cannot remove RNA primers or degrade DNA in the 5' to 3' direction. The absence of this activity is functionally important because it prevents the enzyme from degrading the newly synthesized lagging strand while it is extending Okazaki fragments.

The high processivity of DNA polymerase III is essential for replicating an entire bacterial chromosome in a timely manner. The enzyme can synthesize thousands of nucleotides without dissociating from the template, which allows the replication fork to move rapidly along the chromosome.

Processivity and Its Functional Consequences

Processivity refers to the number of nucleotides a polymerase adds to a growing chain before it dissociates from the template. This property directly determines which enzyme can perform which task during replication.

DNA polymerase III has very high processivity because of its sliding clamp. The clamp holds the polymerase to the template, allowing the enzyme to synthesize long stretches of DNA without falling off. This high processivity is required for the leading strand, which is synthesized continuously for the entire length of the chromosome.

DNA polymerase I has low processivity and adds only a small number of nucleotides before dissociating. This low processivity is appropriate for its role in gap filling because the gaps left after primer removal are short. The enzyme does not need to stay bound for long stretches because its job is limited to replacing short RNA segments with DNA.

The difference in processivity also affects how these enzymes are used in laboratory applications. DNA polymerase I and its Klenow fragment are used in reactions where short stretches of DNA synthesis are needed, such as labeling DNA fragments or filling in recessed ends. DNA polymerase III is not commonly used in laboratory reactions because its multi-subunit structure and clamp requirements make it difficult to work with outside the cell.

Okazaki Fragment Processing

Okazaki fragment processing is the coordinated series of events that converts the discontinuous lagging strand into a continuous DNA strand. This process requires the sequential action of DNA polymerase III, DNA polymerase I, and DNA ligase.

DNA polymerase III extends each Okazaki fragment from its RNA primer until it reaches the RNA primer of the preceding fragment. The polymerase then dissociates, leaving a short RNA primer at the 5' end of the newly synthesized fragment.

DNA polymerase I then binds to the junction between the RNA primer and the DNA of the preceding fragment. The 5' to 3' exonuclease activity of DNA polymerase I removes the RNA primer while the polymerase activity simultaneously fills the gap with DNA. This coupled reaction is called nick translation because the nick moves along the DNA as nucleotides are removed from one side and added to the other.

The final step is sealing the nick by DNA ligase. This enzyme catalyzes the formation of a phosphodiester bond between the 3' hydroxyl of the newly synthesized DNA and the 5' phosphate of the preceding fragment. The result is a continuous sugar-phosphate backbone with no gaps or nicks.

The efficiency of Okazaki fragment processing depends on the proper coordination of these three enzymes. If DNA polymerase I is defective in its 5' to 3' exonuclease activity, RNA primers remain in the lagging strand and the DNA contains ribonucleotide stretches that can cause replication errors in subsequent rounds.

Structural Organization and Subunit Composition

The structural differences between DNA polymerase I and DNA polymerase III reflect their different functional roles.

DNA polymerase I is a relatively simple monomeric enzyme with a molecular weight of approximately 109 kilodaltons in Escherichia coli. The enzyme folds into multiple domains, with the polymerase and 3' to 5' exonuclease activities in one large domain and the 5' to 3' exonuclease activity in a separate N-terminal domain. The active sites for these activities are spatially separated, which allows the enzyme to coordinate primer removal and gap filling.

DNA polymerase III is a complex holoenzyme with a molecular weight of approximately 900 kilodaltons. The holoenzyme contains multiple copies of the catalytic core, the sliding clamp, and the clamp loader. The dimeric structure of the holoenzyme allows it to synthesize the leading and lagging strands simultaneously at the replication fork.

The asymmetric arrangement of the holoenzyme is important for coordinating leading and lagging strand synthesis. The leading strand polymerase remains continuously associated with the template, while the lagging strand polymerase cycles on and off as it completes each Okazaki fragment. The clamp loader facilitates this cycling by loading new clamps onto the template for each new fragment.

These structural differences have practical implications for laboratory work. DNA polymerase I is commercially available as a purified recombinant protein and is used in many standard molecular biology protocols. DNA polymerase III is more difficult to purify and is rarely used in routine laboratory applications.

Practical Workflow for Studying These Polymerases

Laboratory students and researchers who need to study or use DNA polymerase I and DNA polymerase III should follow a structured workflow that includes enzyme selection, reaction design, quality control, and documentation.

Step 1: Define the Experimental Objective

Determine whether the experiment requires high processivity synthesis or short gap filling. DNA polymerase III is appropriate for studies of replication fork movement and processive synthesis. DNA polymerase I is appropriate for primer removal, gap filling, nick translation, and DNA labeling.

Step 2: Select the Appropriate Enzyme Form

For DNA polymerase I, decide whether the full-length enzyme or the Klenow fragment is needed. The full-length enzyme retains the 5' to 3' exonuclease activity and is used for nick translation. The Klenow fragment lacks this activity and is used for fill-in reactions and sequencing.

Step 3: Design Reaction Conditions

Use the buffer and temperature conditions specified by the enzyme manufacturer. Most DNA polymerase I reactions are performed at 37 degrees Celsius. The reaction buffer should contain the appropriate salts and cofactors required for polymerase activity.

Step 4: Include Appropriate Controls

Every experiment should include a positive control with a known template and primer, a negative control without enzyme, and a no-template control. These controls identify problems with reagents, contamination, or reaction conditions.

Step 5: Verify Product Quality

Analyze reaction products by gel electrophoresis or other appropriate methods. Confirm that the product has the expected size and that no degradation or nonspecific products are present.

Step 6: Document Results

Record the enzyme lot number, reaction conditions, and results for each experiment. This documentation supports troubleshooting and ensures reproducibility across experiments.

Records and Measurements

Accurate record keeping is essential for experiments involving DNA polymerases. The following measurements should be recorded for each experiment.

Enzyme activity is measured in units, where one unit is defined as the amount of enzyme that incorporates a specified amount of nucleotide into acid-insoluble material in a specified time at a specified temperature. Record the enzyme concentration and the number of units used in each reaction.

Processivity can be measured by performing reactions with a molar excess of template over enzyme and analyzing the product length distribution. Record the average product length and the distribution of product lengths for each enzyme preparation.

Error rate can be measured using a reporter gene assay or by sequencing reaction products. Record the number of mutations observed and the calculated error rate per nucleotide incorporated.

Reaction efficiency can be measured by quantifying the amount of product synthesized relative to the amount of template provided. Record the percent conversion and any variations between replicate reactions.

These records support quality control and troubleshooting. If a reaction fails, the records allow the researcher to identify whether the problem was in the enzyme, the reagents, the template, or the reaction conditions.

Quality Controls and Troubleshooting

Quality control for DNA polymerase experiments includes verifying enzyme activity, checking for contamination, and confirming reaction specificity.

Enzyme activity should be verified with a standard reaction using a known template and primer. If the enzyme fails to produce the expected product, the enzyme may be inactive or the reaction conditions may be incorrect.

Contamination can introduce nucleases that degrade the template or product. Use sterile reagents and clean equipment to minimize contamination. Include a no-template control to detect contaminating DNA in the reagents.

Reaction specificity can be confirmed by analyzing the product size and sequence. Nonspecific products may indicate incorrect annealing conditions, excessive enzyme, or contamination with nucleases.

Common failure patterns in DNA polymerase experiments include no product, smeared products, truncated products, and unexpected product sizes. Each failure pattern has specific causes that can be identified through systematic troubleshooting.

No product may result from inactive enzyme, incorrect buffer, missing cofactors, or a template that does not anneal to the primer. Smeared products may result from nuclease contamination or excessive reaction time. Truncated products may result from secondary structure in the template or from premature termination by the polymerase. Unexpected product sizes may result from primer misannealing or from template contamination.

Common Failure Patterns in Replication Studies

Studies of DNA polymerase function in prokaryotic systems can fail for several reasons. Understanding these failure patterns helps researchers design better experiments and interpret results correctly.

Temperature sensitivity is a common issue. DNA polymerase I is heat-labile and loses activity at temperatures above 37 degrees Celsius. If reactions are incubated at higher temperatures, the enzyme may be inactivated before synthesis is complete.

Metal ion dependence is another common issue. DNA polymerases require magnesium ions for activity. If the magnesium concentration is too low, polymerase activity is reduced. If the magnesium concentration is too high, the proofreading exonuclease activity may dominate and degrade the product.

Primer template mismatches can cause replication errors. The 3' to 5' exonuclease activity of both polymerases removes mismatched nucleotides, but if the mismatch is at the primer terminus, the polymerase may stall or dissociate.

Inhibitors in the reaction can reduce polymerase activity. Common inhibitors include salts, detergents, and organic solvents that may be present in template preparations. Purifying the template and using clean reagents reduces the risk of inhibition.

Biosafety and Laboratory Practices

Work with DNA polymerases and bacterial cultures requires adherence to standard laboratory biosafety practices. The World Health Organization Laboratory Biosafety Manual provides guidance on safe handling of biological materials and laboratory operations. Laboratories should follow the biosafety level appropriate for the organisms and materials being used.

Standard practices include wearing laboratory coats and gloves, performing work in designated areas, decontaminating work surfaces after use, and properly disposing of biological waste. These practices protect laboratory workers and prevent contamination of experiments.

The World Health Organization Laboratory Quality Management System Handbook emphasizes the importance of quality control, documentation, and continuous improvement in laboratory operations. These principles apply to research laboratories as well as diagnostic laboratories. Maintaining accurate records, validating methods, and participating in proficiency testing support reliable results.

When working with recombinant DNA and bacterial strains, follow institutional biosafety committee requirements and any applicable regulations. These requirements may include specific containment practices, training, and approval before work begins.

Limitations of Current Knowledge

Several limitations exist in the current understanding of DNA polymerase function in prokaryotic replication.

The detailed mechanisms of polymerase switching between DNA polymerase III and DNA polymerase I during Okazaki fragment processing are not fully characterized. The precise signals that trigger polymerase III to dissociate and polymerase I to bind are still under investigation.

The regulation of polymerase expression and activity in response to cellular conditions is not completely understood. Cells may adjust polymerase levels or activity in response to DNA damage, growth phase, or other environmental signals.

The interactions between DNA polymerases and other replication proteins are complex and not fully mapped. The replication machinery includes helicases, primases, single-stranded binding proteins, and other factors that coordinate with the polymerases.

Iron-sulfur clusters have been identified as components of some DNA replication and repair proteins across all domains of life. Research has shown that these cofactors are present in cytosolic and nuclear proteins involved in DNA replication and repair, telomere maintenance, and cell cycle regulation. The role of iron-sulfur clusters in prokaryotic DNA polymerases specifically is an area of ongoing investigation.

These limitations mean that laboratory results should be interpreted with appropriate caution. Observations that seem inconsistent with textbook models may reflect real biological complexity instead of experimental error.

Professional Escalation Criteria

Laboratory personnel should escalate problems to a supervisor or principal investigator when they encounter situations that exceed their training or expertise.

Escalate when an experiment fails repeatedly despite troubleshooting. Repeated failure may indicate a problem with the enzyme preparation, the template, or the experimental design that requires expert review.

Escalate when results are inconsistent with established controls or with published data. Inconsistency may indicate a systematic error in the experimental protocol or a problem with the reagents.

Escalate when contamination is suspected in cultures or reagents. Contamination can compromise experimental results and may pose a biosafety risk that requires professional assessment.

Escalate when equipment malfunctions affect experimental results. Equipment problems may require professional repair or recalibration before reliable data can be obtained.

Escalate when there is uncertainty about the interpretation of results. Professional review can help distinguish between meaningful biological variation and experimental artifacts.

Frequently Asked Questions

What is the main difference between DNA polymerase I and DNA polymerase III?

DNA polymerase III is the primary replicative enzyme that synthesizes new DNA strands during chromosome replication. DNA polymerase I removes RNA primers from Okazaki fragments and fills the resulting gaps with DNA. DNA polymerase III has high processivity and lacks 5' to 3' exonuclease activity, while DNA polymerase I has low processivity and possesses 5' to 3' exonuclease activity.

Why does DNA polymerase III have high processivity?

DNA polymerase III achieves high processivity through its sliding clamp, a ring-shaped protein that encircles the DNA template and holds the polymerase to the template. This clamp prevents the polymerase from dissociating after each nucleotide addition, allowing the enzyme to synthesize long stretches of DNA without falling off.

Why does DNA polymerase I have 5' to 3' exonuclease activity?

DNA polymerase I uses its 5' to 3' exonuclease activity to remove RNA primers from the lagging strand during Okazaki fragment processing. This activity cleaves the RNA portion of the RNA-DNA junction while leaving the DNA intact, allowing the polymerase to fill the gap with DNA.

What is the Klenow fragment?

The Klenow fragment is a proteolytic cleavage product of DNA polymerase I that retains the 5' to 3' polymerase activity and the 3' to 5' exonuclease activity but lacks the 5' to 3' exonuclease activity. It is used in molecular biology for DNA labeling, fill-in reactions, and sequencing because it does not degrade primers or products.

Can DNA polymerase I substitute for DNA polymerase III?

No, DNA polymerase I cannot substitute for DNA polymerase III because it has low processivity and cannot synthesize the long stretches of DNA required for chromosome replication. DNA polymerase I also lacks the sliding clamp and clamp loader components that enable high processivity.

What happens if DNA polymerase I is defective?

If DNA polymerase I is defective in its 5' to 3' exonuclease activity, RNA primers remain in the lagging strand and are not replaced with DNA. This leaves ribonucleotide stretches in the DNA that can cause replication errors and genome instability in subsequent rounds of replication.

How do the proofreading activities of these polymerases differ?

Both DNA polymerase I and DNA polymerase III have 3' to 5' exonuclease proofreading activities that remove mismatched nucleotides. The proofreading activity of DNA polymerase III is part of the epsilon subunit in the catalytic core, while the proofreading activity of DNA polymerase I is in the same polypeptide as the polymerase activity.

Why is DNA polymerase III not commonly used in laboratory reactions?

DNA polymerase III is not commonly used in laboratory reactions because it is a large multi-subunit complex that requires the sliding clamp, clamp loader, and ATP for high processivity. This complexity makes the enzyme difficult to purify and use outside the cell. DNA polymerase I and its Klenow fragment are simpler and more practical for routine molecular biology applications.

Related Diagnostic Guides

• Understanding the Role of DNA Polymerase I in Nick Translation and Labeling
• Understanding DNA Ligase: Mechanism, Types, and Role in Replication and Cloning
• How to Store and Handle Taq Polymerase for Long-Term Use
• Understanding Ct Values in qPCR: What They Mean and How to Use Them
• DNA Extraction from Hair Follicles: Protocol for Forensic and Research Use

References and Further Reading

• Laboratory Quality Management System Handbook. World Health Organization.
• Laboratory Biosafety Manual. World Health Organization.
• Assay Guidance Manual. National Center for Advancing Translational Sciences.
• Bioanalytical Method Validation Guidance. U.S. Food and Drug Administration.
• NCBI Literature Resources. National Center for Biotechnology Information.
• Iron-sulfur cofactors in nucleic acid metabolism and protein synthesis: Assembly, delivery, and putative roles in cellular and viral systems.. 2026.
• Emerging roles of POLR2L of RNA polymerase II dynamics and disease mechanisms (Review).. 2026.
• Roles of ADP-Ribosyltransferases in Cancer.. 2026.
• In vivo immunoprotective comparison between recombinant protein and DNA vaccine of Eimeria tenella surface antigen 4.. Veterinary parasitology, 2020.
• Characterization of the DNA of the hamster papovavirus: II. A comparison of binding sites for Escherichia coli- and calf thymus RNA polymerase II on the hamster papovavirus genome.. Biomedica biochimica acta, 1985.
• The primary structure of Plasmodium falciparum DNA polymerase δ is similar to drug sensitive δ-like viral DNA polymerases. 1991.
• Biochemical Analysis of Point Mutations in the 5′-3′ Exonuclease of DNA Polymerase I of Streptococcus pneumoniae. Journal of Biological Chemistry, 2001.
• Anti-RNA polymerase III antibody prevalence and associated clinical manifestations in a large series of French patients with systemic sclerosis: A cross-sectional study. Journal of Rheumatology, 2010.
• Different doses of recombinant alpha interferon in the treatment of chronic hepatitis B patients without antibodies against the human immunodeficiency. Hepato Gastroenterology, 1988.
• GSTM1 and codon 72 P53 polymorphism in multiple myeloma. Annals of Hematology, 2007.

This article is educational and does not replace validated laboratory procedures, institutional biosafety review, manufacturer instructions, or professional interpretation.